Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-10-31
1994-10-04
Elliott, George C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530326, 435214, 424 9464, A61K 3702, A61K 37547, C07K 710, C12N 974
Patent
active
053526643
ABSTRACT:
Thrombin is now known to mediate a number of potent biological effects on cells bearing high-affinity thrombin receptors. These effects depend, at least in part, upon receptor occupancy signals generated by thrombin's interaction with the high affinity thrombin receptor. The present inventors have formulated synthetic thrombin derivatives capable of selectively stimulating or inhibiting thrombin receptor occupancy signals. The stimulatory thrombin derivatives to bind to cell surface thrombin receptors and stimulate DNA synthesis in cells treated with non-mitogenic concentrations of alpha-thrombin or phorbol myristate acetate. Thus, these peptides, which have both a thrombin receptor binding domain and a segment of amino acids with a sequence common to a number of serine proteases, appear to generate receptor-occupancy dependent mitogenic signals. The inhibitory derivatives, which have no serine esterase conserved amino acid sequences bind to thrombin receptors without generating receptor-occupancy dependent mitogenic signals. This invention describes the peptides and methods for using them to promote cell growth and wound healing or to inhibit scar formation, tissue adhesions, and tumor metastasis and angiogenesis.
REFERENCES:
patent: 4427651 (1984-01-01), Stroetmann
patent: 4606337 (1986-08-01), Zimmermann et al.
Butkowski et al. (1977) JBC, 252:4942-4957, "Primary Structure of Human Prethrombin 2 and .alpha.-Thrombin".
Ruoslahti and Pierschbacher (1986), Cell, 44:517-518.
Carney et al. (1985), Cell, 42:470-488.
Carney et al. (1984), J. Cell. Biochem., 26:181-195.
Pierschbacher and Ruoslahti (1984), Proc. Natl. Acad. Sci. USA, 81:5985-5988.
Pierschbacher and Ruoslahti (1984), Nature, 309:30-33.
Degen et al. (1983), Biochem., 22:2087-2097.
Perdue et al. (1981), J. Biolog. Chem., 256:2767-2776.
Glenn et al. (1980), J. Biolog. Chem., 255:6609-6616.
Carney and Cunningham (1978), Cell, 15:1341-1349.
Carney and Cunningham (1978), Cell, 14:811-823.
Chen and Buchanan (1975), Proc. Natl. Acad. Sci. USA, 72:131-135.
CA vol. 102, 1985 Ginsberg et al.
CA vol. 90, 1979 Asstov et al.
Carney Darrell H.
Glenn Kevin C.
Board of Regents , The University of Texas System
Elliott George C.
Monsanto Company
LandOfFree
Thrombin derived polypeptides; compositions and methods for use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombin derived polypeptides; compositions and methods for use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombin derived polypeptides; compositions and methods for use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581354